Paul Peter Tak, Chief Executive Officer at Candel Therapeutics, Inc. (CADL), bought 25,000 shares at $8.00 ($200K) on 2021-07-29, disclosed to the SEC on 2021-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CADL | SELL | 2025-01-17 | $314K | — | Filing → |
| CADL | SELL | 2025-01-10 | $348K | — | Filing → |
| CADL | SELL | 2024-12-03 | $445K | — | Filing → |